ArticleCEN case reports2026
Diagnosis of fibrillary glomerulonephritis suggests possible atypical familial Mediterranean fever in a patient with ulcerative colitis.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrillary glomerulonephritis (FGN) is a rare glomerular disease that typically presents in middle age, and reports in young adults are uncommon. Herein, we describe the case of a 22-year-old woman with ulcerative colitis who was referred for evaluation of persistent proteinuria and microscopic hematuria. Kidney biopsy showed mild mesangial hypercellularity with increased mesangial matrix on light microscopy. Electron microscopy revealed randomly oriented, nonbranching microfibrils measuring approximately 20 nm in diameter within the mesangial areas. Immunohistochemistry for DnaJ heat shock protein family member B9 (DNAJB9) was positive in the glomeruli, confirming the diagnosis of FGN. Given the unusually young onset, the clinical course, and the presence of intestinal inflammatory lesions, an autoinflammatory disorder, specifically atypical familial Mediterranean fever (FMF), was suspected. Therapy with an angiotensin II receptor blocker was initiated for proteinuria, and colchicine was subsequently added while mesalazine was tapered. After treatment, urinary protein excretion decreased, and endoscopic and histologic bowel inflammation improved. This case highlights three practical points: DNAJB9 immunostaining is useful to establish FGN when classic ultrastructural features are present, FGN can occur in young adults, prompting evaluation for underlying systemic or autoinflammatory conditions, and in patients with intestinal lesions resembling inflammatory bowel disease, consideration of FMF may lead to colchicine therapy that benefits renal and gastrointestinal manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.